$1.27 Billion in Sales Expected for CME Group Inc. (NASDAQ:CME) This Quarter

Brokerages expect CME Group Inc. (NASDAQ:CMEGet Rating) to report sales of $1.27 billion for the current quarter, Zacks Investment Research reports. Six analysts have issued estimates for CME Group’s earnings, with estimates ranging from $1.18 billion to $1.32 billion. CME Group posted sales of $1.25 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 1.6%. The firm is scheduled to issue its next quarterly earnings report before the market opens on Monday, January 1st.

On average, analysts expect that CME Group will report full-year sales of $4.96 billion for the current year, with estimates ranging from $4.66 billion to $5.18 billion. For the next financial year, analysts forecast that the company will report sales of $5.24 billion, with estimates ranging from $4.95 billion to $5.47 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for CME Group.

CME Group (NASDAQ:CMEGet Rating) last released its earnings results on Wednesday, February 9th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. CME Group had a return on equity of 8.93% and a net margin of 56.22%. The company had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same period in the prior year, the firm posted $1.39 EPS.

A number of brokerages have commented on CME. Raymond James upped their price target on shares of CME Group from $240.00 to $265.00 and gave the company an “outperform” rating in a research report on Thursday, February 10th. UBS Group decreased their price target on CME Group from $275.00 to $269.00 in a report on Tuesday, April 5th. Rosenblatt Securities decreased their target price on CME Group from $268.00 to $267.00 and set a “neutral” rating for the company in a research report on Thursday. Citigroup reduced their target price on shares of CME Group from $280.00 to $275.00 in a research note on Wednesday. Finally, StockNews.com began coverage on shares of CME Group in a report on Thursday, March 31st. They issued a “hold” rating on the stock. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $252.85.

In other news, insider Kevin Kometer sold 13,500 shares of CME Group stock in a transaction that occurred on Thursday, February 10th. The stock was sold at an average price of $244.04, for a total value of $3,294,540.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction on Thursday, February 10th. The stock was sold at an average price of $244.36, for a total value of $733,080.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,650 shares of company stock worth $7,814,564. 0.30% of the stock is currently owned by corporate insiders.

Large investors have recently bought and sold shares of the business. BlackRock Inc. raised its position in CME Group by 3.6% in the 3rd quarter. BlackRock Inc. now owns 25,552,312 shares of the financial services provider’s stock valued at $4,941,308,000 after purchasing an additional 880,410 shares during the last quarter. State Street Corp boosted its stake in shares of CME Group by 2.3% in the fourth quarter. State Street Corp now owns 16,862,546 shares of the financial services provider’s stock valued at $3,906,238,000 after buying an additional 377,321 shares in the last quarter. Capital International Investors increased its holdings in shares of CME Group by 26.9% in the 4th quarter. Capital International Investors now owns 13,188,121 shares of the financial services provider’s stock valued at $3,013,006,000 after purchasing an additional 2,795,636 shares in the last quarter. Capital Research Global Investors grew its holdings in shares of CME Group by 7.1% in the 4th quarter. Capital Research Global Investors now owns 9,100,458 shares of the financial services provider’s stock worth $2,079,091,000 after acquiring an additional 603,755 shares during the period. Finally, Parnassus Investments LLC raised its stake in shares of CME Group by 15.5% during the 3rd quarter. Parnassus Investments LLC now owns 7,097,398 shares of the financial services provider’s stock worth $1,372,495,000 after buying an additional 951,681 shares during the last quarter. Institutional investors and hedge funds own 84.58% of the company’s stock.

CME Group stock opened at $237.66 on Friday. The stock has a 50-day moving average price of $239.49 and a two-hundred day moving average price of $228.00. CME Group has a 12 month low of $185.79 and a 12 month high of $256.94. The company has a market capitalization of $85.42 billion, a PE ratio of 32.51, a P/E/G ratio of 3.68 and a beta of 0.43. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10.

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 25th. Investors of record on Thursday, March 10th were paid a $1.00 dividend. The ex-dividend date of this dividend was Wednesday, March 9th. This represents a $4.00 annualized dividend and a yield of 1.68%. This is a boost from CME Group’s previous quarterly dividend of $0.90. CME Group’s dividend payout ratio is 54.72%.

CME Group Company Profile (Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

Featured Articles

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.